Skip to main content
SpringerLink
Log in

Immunodeficiency-Associated Lymphoproliferative Disorders Other Than PTLD (in Primary Immune Deficiency, HIV, and Iatrogenic Conditions)

  • Chapter
  • First Online:
Practical Lymph Node and Bone Marrow Pathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 1511 Accesses

Abstract

This chapter discusses the three categories of lymphoproliferative disorders arising from immune deficiencies: primary immune deficiency, human immunodeficiency virus (HIV) infection, and iatrogenic medication. Posttransplant lymphoproliferative disorder is discussed in a separate chapter. In all three categories, various forms of immune suppression result in increased risks of developing lymphoproliferative disorders. In primary immune deficiency, compromised humoral immunity, cellular immunity, or both are associated with inherited or congenital disorders that result in increased incidence of lymphoid neoplasms. These lymphomas most commonly arise in children and young adults. In HIV infection, cellular immunities are compromised by direct viral infection of helper/inducer T cells. In conditions associated with iatrogenic medication, lymphomas arise after prolonged immune suppression by cytotoxic chemotherapy or immune modulatory therapy. These drugs suppress and modulate cellular and humoral immunities resulting in immunologic dysregulation and lymphoid hyperactivation. Although the etiologies of the immune deficiencies vary in these disorders, they result in similar consequences with dysregulation and suppression of immune system and increased risk of lymphomas most commonly EBV-driven large cell and aggressive lymphomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin North Am. 2008;28:367–86.

    Article  Google Scholar 

  2. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489–502.

    Article  Google Scholar 

  3. Kalman L, Lindegren ML, Kobrynski L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med. 2004;6:16–26.

    Google Scholar 

  4. Schuetz C, Huck K, Gudowius S, Megahed M, Feyen O, Hubner B, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008;358:2030–8.

    Google Scholar 

  5. Qamar N, Fuleihan RL. The hyper IgM syndromes. Clin Rev Allergy Immunol. 2014;46:120–30.

    Article  CAS  Google Scholar 

  6. Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258:427–9.

    Google Scholar 

  7. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet. 1995;4:2025–32.

    Google Scholar 

  8. Derry JMJ, Ochs HD, Francke U. Pillars Article: Isolation of a Novel Gene Mutated in Wiskott-Aldrich Syndrome. Cell. 1994;78:635–44. J Immunol. 2018;200:3671–80

    Article  CAS  Google Scholar 

  9. Featherstone C. How does one gene cause Wiskott-Aldrich syndrome? Lancet. 1996;348:950.

    Article  CAS  Google Scholar 

  10. Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol. 2011;152:13–30.

    Article  CAS  Google Scholar 

  11. Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011;117:53–62.

    Google Scholar 

  12. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89:1341–8.

    Google Scholar 

  13. Shah S, Wu E, Rao VK, Tarrant TK. Autoimmune lymphoproliferative syndrome: an update and review of the literature. Curr Allergy Asthma Rep. 2014;14:462.

    Google Scholar 

  14. Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123:1989–99.

    Google Scholar 

  15. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541–50.

    Google Scholar 

  16. Bleesing JJ, Brown MR, Straus SE, Dale JK, Siegel RM, Johnson M, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood. 2001;98:2466–73.

    Google Scholar 

  17. Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–40.

    Google Scholar 

  18. Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170–82.

    Google Scholar 

  19. Caballero FM, Brown WR, Kohler PF, Hayward AR. B cell numbers and responses in patients with common variable immunodeficiency and nodular lymphoid hyperplasia of the bowel. J Clin Lab Immunol. 1984;13:59–63.

    Google Scholar 

  20. Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20:1240–52.

    Google Scholar 

  21. Hugle B, Astigarraga I, Henter JI, Porwit-MacDonald A, Meindl A, Schuster V. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease. Eur J Pediatr. 2007;166:589–93.

    Article  Google Scholar 

  22. Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22:261–81.

    Article  Google Scholar 

  23. Tinguely M, Vonlanthen R, Muller E, Dommann-Scherrer CC, Schneider J, Laissue JA, et al. Hodgkin’s disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states. Mod Pathol. 1998;11:307–12.

    Google Scholar 

  24. Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Investig. 1985;3:515–22.

    Google Scholar 

  25. Ilowite NT, Fligner CL, Ochs HD, Brichacek B, Harada S, Haas JE, et al. Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection. Clin Immunol Immunopathol. 1986;41:479–84.

    Google Scholar 

  26. Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423–38.

    Google Scholar 

  27. Miller B, Stansfield SK, Zack MM, Curran JW, Kaplan JE, Schonberger LB, et al. The syndrome of unexplained generalized lymphadenopathy in young men in New York City. Is it related to the acquired immune deficiency syndrome? JAMA. 1984;251:242–6.

    Google Scholar 

  28. Mathur-Wagh U, Enlow RW, Spigland I, Winchester RJ, Sacks HS, Rorat E, et al. Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome. Lancet. 1984;1:1033–8.

    Google Scholar 

  29. O’Murchadha MT, Wolf BC, Neiman RS. The histologic features of hyperplastic lymphadenopathy in AIDS-related complex are nonspecific. Am J Surg Pathol. 1987;11:94–9.

    Article  Google Scholar 

  30. Finfer MD, Schinella RA, Rothstein SG, Persky MS. Cystic parotid lesions in patients at risk for the acquired immunodeficiency syndrome. Arch Otolaryngol Head Neck Surg. 1988;114:1290–4.

    Article  CAS  Google Scholar 

  31. Terry JH, Loree TR, Thomas MD, Marti JR. Major salivary gland lymphoepithelial lesions and the acquired immunodeficiency syndrome. Am J Surg. 1991;162:324–9.

    Article  CAS  Google Scholar 

  32. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, et al. Multicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996;10:61–7.

    Google Scholar 

  33. Katchanov J, Zimmermann U, Branding G, Arasteh K, Muller M. HIV-associated multicentric Castleman’s disease after initiation of antiretroviral therapy: experience of a European Centre. Infection. 2014;42:791–3.

    Google Scholar 

  34. Pileri S, Rivano MT, Raise E, Gualandi G, Gobbi M, Martuzzi M, et al. The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex (ARC): a morphological and immunohistochemical study of 90 cases. Histopathology. 1986;10:1107–29.

    Google Scholar 

  35. Biberfeld P, Ost A, Porwit A, Sandstedt B, Pallesen G, Bottiger B, et al. Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A. 1987;95:47–65.

    Google Scholar 

  36. Chadburn A, Metroka C, Mouradian J. Progressive lymph node histology and its prognostic value in patients with acquired immunodeficiency syndrome and AIDS-related complex. Hum Pathol. 1989;20:579–87.

    Article  CAS  Google Scholar 

  37. Weiss LM, O’Malley D. Benign lymphadenopathies. Mod Pathol. 2013;26:S88–96.

    Article  CAS  Google Scholar 

  38. Raphael MM, Audouin J, Lamine M, Delecluse HJ, Vuillaume M, Lenoir GM, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. Am J Clin Pathol. 1994;101:773–82.

    Google Scholar 

  39. Kasamon YL, Ambinder RF. AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19:665–87.

    Article  Google Scholar 

  40. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med. 1991;115:15–20.

    CAS  PubMed  Google Scholar 

  41. Davi F, Delecluse HJ, Guiet P, Gabarre J, Fayon A, Gentilhomme O, et al. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. Burkitt’s Lymphoma Study Group. J Clin Oncol. 1998;16:3788–95.

    Google Scholar 

  42. Bibas M, Castillo JJ. Current knowledge on HIV-associated plasmablastic lymphoma. Mediterr J Hematol Infect Dis. 2014;6:e2014064.

    Article  Google Scholar 

  43. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood. 1996;88:645–56.

    Google Scholar 

  44. Guillet S, Gerard L, Meignin V, Agbalika F, Cuccini W, Denis B, et al. Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution. Am J Hematol. 2016;91:233–7.

    Google Scholar 

  45. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, et al. Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol. 1995;13:1758–67.

    Google Scholar 

  46. Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 2009;113:5737–42.

    Google Scholar 

  47. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol. 2003;27:293–302.

    Article  Google Scholar 

  48. Bellan C, De Falco G, Lazzi S, Leoncini L. Pathologic aspects of AIDS malignancies. Oncogene. 2003;22:6639–45.

    Article  CAS  Google Scholar 

  49. Pelicci PG, Knowles DM 2nd, Magrath I, Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1986;83:2984–8.

    Article  CAS  Google Scholar 

  50. Liapis K, Clear A, Owen A, Coutinho R, Greaves P, Lee AM, et al. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood. 2013;122:424–33.

    Google Scholar 

  51. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood. 1993;81:166–76.

    Google Scholar 

  52. Okano M, Gross TG. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci. 2000;319:392–6.

    Article  CAS  Google Scholar 

  53. Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. 2016:462–4.

    Google Scholar 

  54. Kinlen L. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996. p. 532–45.

    Google Scholar 

  55. Farrell RJ, Ang Y, Kileen P, O’Briain DS, Kelleher D, Keeling PW, et al. Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut. 2000;47:514–9.

    Google Scholar 

  56. Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13:847–58.e4; quiz e48–50

    Google Scholar 

  57. Pina-Oviedo S, Miranda RN, Medeiros LJ. Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder. Am J Surg Pathol. 2018;42:116–29.

    Article  Google Scholar 

  58. Hasserjian RP, Chen S, Perkins SL, de Leval L, Kinney MC, Barry TS, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532–40.

    Google Scholar 

  59. Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med. 2008;168:378–81.

    Google Scholar 

  60. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943–9.

    Google Scholar 

  61. Abruzzo LV, Rosales CM, Medeiros LJ, Vega F, Luthra R, Manning JT, et al. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. Am J Surg Pathol. 2002;26:630–6.

    Google Scholar 

  62. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, et al. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia. 2009;23:1398–405.

    Google Scholar 

  63. Ozawa MG, Ewalt MD, Gratzinger D. Dasatinib-related follicular hyperplasia: an underrecognized entity with characteristic morphology. Am J Surg Pathol. 2015;39:1363–9.

    Google Scholar 

  64. Giard C, Avenel-Audran M, Croue A, Verret JL, Martin L. Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate. J Clin Oncol. 2010;28:e717–8.

    Google Scholar 

  65. Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322–31.

    Google Scholar 

  66. Bhamidipati PK, Jabbour E, Konoplev S, Estrov Z, Cortes J, Daver N. Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine. Clin Lymphoma Myeloma Leuk. 2013;13:342–6.

    Google Scholar 

  67. Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, et al. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2013;37:1290–7.

    Google Scholar 

  68. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer–a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34:405–17.

    Google Scholar 

  69. Roberts TK, Chen X, Liao JJ. Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Exp Hematol Oncol. 2015;5:13. https://doi.org/10.1186/s40164-016-0042-5.

  70. Gibson SE, Swerdlow SH, Craig FE, Surti U, Cook JR, Nalesnik MA, et al. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol. 2011;35:807–15.

    Google Scholar 

  71. Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, et al. EBV-positive B-cell proliferations of varied malignant potential: 2015 SH/EAHP workshop report-part 1. Am J Clin Pathol. 2017;147:129–52.

    Google Scholar 

  72. O’Neill BP, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro-Oncology. 2007;9:364–9.

    Google Scholar 

  73. Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, et al. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget. 2015;6:33849–66.

    Google Scholar 

  74. Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED. Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk. Eur J Gastroenterol Hepatol. 2011;23:1150–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA

    Jerald Z. Gong & Guldeep Uppal

  2. The Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, USA

    Siraj M. El Jamal

Authors
  1. Jerald Z. Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siraj M. El Jamal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guldeep Uppal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerald Z. Gong .

Editor information

Editors and Affiliations

  1. Department of Pathology, Duke University School of Medicine and Duke Health System, Durham, NC, USA

    Endi Wang

  2. Department of Pathology, Duke University School of Medicine and Duke Health System, Durham, NC, USA

    Anand Shreeram Lagoo

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gong, J.Z., El Jamal, S.M., Uppal, G. (2020). Immunodeficiency-Associated Lymphoproliferative Disorders Other Than PTLD (in Primary Immune Deficiency, HIV, and Iatrogenic Conditions). In: Wang, E., Lagoo, A.S. (eds) Practical Lymph Node and Bone Marrow Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-32189-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-32189-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-32188-8

  • Online ISBN: 978-3-030-32189-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation